About NYU Pain Management Center
Clinical Trials at NYU Pain Management Center
During the past decade, NYU Pain Management Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "NYU Pain Management Center" #1 sponsor was "Cephalon" with 2 trials, followed by "Sucampo Pharma Americas, LLC" with 2 trials
sponsored, "Elan Pharmaceuticals" with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Zogenix, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Pain Management Center"
#1 collaborator was "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at NYU Pain Management Center
According to Clinical.Site data, the most researched conditions in "NYU Pain Management Center" are
"Opioid-Induced Bowel Dysfunction" (2 trials), "Pain" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Cancer" (1 trials) and "Chronic Pain" (1 trials). Many other conditions were trialed in "NYU Pain Management Center" in a lesser frequency.
Clinical Trials Intervention Types at NYU Pain Management Center
Most popular intervention types in "NYU Pain Management Center" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Hydrocodone Bitartrate" (1 trials), "Ibuprofen" (1 trials), "Lubiprostone" (1 trials), "Lubiprostone 24" (1 trials) and "Naproxen" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NYU Pain Management Center
The vast majority of trials in "NYU Pain Management Center" are
7 trials for "All" genders.
Clinical Trials Status at NYU Pain Management Center
Currently, there are NaN active trials in "NYU Pain Management Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in NYU Pain Management Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in NYU Pain Management Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".